Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedMay 4, 2022RE-1, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . Alprostadil 200 mcg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0813-2022Class IITerminatedMay 4, 2022QM-4, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . Alprostadil 300 mcg/mL . Atropine 0.2 mg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0812-2022Class IITerminatedMay 4, 2022QM-3, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . Alprostadil 150 mcg/mL . Atropine 0.2 mg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0811-2022Class IITerminatedMay 4, 2022ST-2, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . Alprostadil 100 mcg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0810-2022Class IITerminatedMay 4, 2022ST-1, Papaverine 30 mg/mL . Phentolamine 1.5 mg/mL . Alprostadil 50 mcg/mlCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0809-2022Class IITerminatedMay 4, 2022SB-6, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . PGE 60 mcg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0808-2022Class IITerminatedMay 4, 2022SB-5, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . PGE 50 mcg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0807-2022Class IITerminatedMay 4, 2022SB-4, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . Alprostadil 40 mcg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0806-2022Class IITerminatedMay 4, 2022T-101, Papaverine 17.65 mg/mL . Phentolamine 0.59 mg/mL . Alprostadil 5.9 mcg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0805-2022Class IITerminatedMay 4, 2022T-106, Papaverine 30 mg/mL . Phentolamine 1 mg/mL . Alprostadil 25 mcg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0804-2022Class IITerminatedMay 4, 2022NB-243, Papaverine 30mg/ml . Phentolamine 3mg/ml . Alprostadil 20mcg/mlCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0803-2022Class IITerminatedMay 4, 2022AT-1, Papaverine 8mg/ml . Phentolamine 2mg/ml . Atropine 0.2mg/mlCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0802-2022Class IITerminatedMay 4, 2022AT-6, Papaverine 40mg/ml . Phentolamine 4mg/ml . Atropine 0.3mg/mlCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0801-2022Class IITerminatedMay 4, 2022Formula F9CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0800-2022Class IITerminatedMay 4, 2022T-105, Papaverine 30mg/mL . Phentolamine 1mg/ml . PGE 10mcg/mlCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0799-2022Class IITerminatedMay 4, 2022QM-2 Papaverine 30 mg/mL. Phentolamine 3 mg/mL . Alprostadil 60 mcg/mL . Atropine 0.2 mg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0798-2022Class IITerminatedMay 4, 2022Sermorelin AcetateCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0797-2022Class IITerminatedMay 4, 2022Diluent for Reconstitution Each ML contains: 1.5% Benzyl Alcohol NFCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0796-2022Class IITerminatedMay 4, 2022NAD+ Nicotinamide Adenine Dinucleotide Lyophilized powder for reconstitutionCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0795-2022Class IITerminatedMay 4, 2022Lidocaine 2.5% and Prilocaine 2.5% CreamcGMP DeviationsTeva Pharmaceuticals USA Inc · D-0794-2022Class IICompletedMay 4, 2022Zonisamide CapsulescGMP deviationsGlenmark Pharmaceuticals Inc., USA · D-0793-2022Class IICompletedMay 4, 2022Zonisamide CapsulescGMP deviationsGlenmark Pharmaceuticals Inc., USA · D-0792-2022Class IICompletedMay 4, 2022Zonisamide Capsules USPcGMP deviationsGlenmark Pharmaceuticals Inc., USA · D-0791-2022Class IIITerminatedMay 4, 2022Cyanocobalamin InjectionSubpotent Drug: Out of specification for assay.American Health Packaging · D-0790-2022Class IITerminatedMay 4, 2022Losartan Potassium Tab. USP 50mgCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.Preferred Pharmaceuticals, Inc. · D-0789-2022Class IITerminatedMay 4, 2022Losartan Potassium 50 mg TabletCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.RemedyRepack Inc. · D-0788-2022Class IIITerminatedMay 4, 2022Wal-Tussin DMIncorrect/Undeclared Excipient: Product contains alcoholAptaPharma Inc. · D-0787-2022Class IITerminatedMay 4, 2022TORCO RACING FUELS HAND SANITIZERCGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.Torco Race Fuels · D-0786-2022Class IIOngoingMay 4, 2022Suave 24-Hour Protection Aerosol Antiperspirant Fresh scentCGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzeneUnilever United States Inc. · D-0211-2024Class IOngoingMay 4, 2022Suave 24-Hour Protection Aerosol Antiperspirant Powder scentChemical contamination: presence of benzeneUnilever United States Inc. · D-0210-2024Class ITerminatedApr 27, 2022Pink Pussycat SENSUAL ENHANCEMENT capsuleMarketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of...Pink Toyz · D-0785-2022Class IITerminatedApr 27, 2022artnaturals Hand SanitizerCGMP Deviations: Other lots recalled because they were manufactured using common ingredients as the contaminated lotVirgin Scent Inc · D-0784-2022Class IITerminatedApr 27, 2022artnaturals hand sanitizerCGMP Deviations: Other lots recalled because they were manufactured using common ingredients as the contaminated lotVirgin Scent Inc · D-0783-2022Class ITerminatedApr 27, 2022artnaturals hand sanitizerChemical Contamination: presence of benzene, acetaldehyde, and acetal.Virgin Scent Inc · D-0782-2022Class IITerminatedApr 27, 2022Sermorelin Acetate 1 mg/mLLack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding · D-0781-2022Class IITerminatedApr 27, 2022PT-141 (Bremelanotide Acetate) 10 mg/mLLack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding · D-0780-2022Class IITerminatedApr 27, 2022Melanotan II 1 mg/mLLack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding · D-0779-2022Class IITerminatedApr 27, 2022LL-37 2 mg/mLLack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding · D-0778-2022Class IITerminatedApr 27, 2022Ipamorelin Acetate/Sermorelin AcetateLack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding · D-0777-2022Class IITerminatedApr 27, 2022BPC-157 2 mg/mLLack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding · D-0776-2022